DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01209 RJ7 AKKAWKKAKKAAKKAKKWAKK HSV 15498607
DRAVPe01210 RJ8 ARRAWRRARRAARRARRAARR HSV 15498607
DRAVPe01211 RJ9 ARRAKRRARRAARRARRKARR HSV 15498607
DRAVPe01212 RJ10 ARRAKRRARRAKRRARRKKRR HSV 15498607
DRAVPe01303 Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals) ATCYCRTGRCATRESLSGVCEISGRLYRLCCR SARS-CoV-2,HSV,HIV 34206990,26206286,23269800
DRAVPe01304 HD5[E21R] ATCYCRTGRCATRESLSGVCRISGRLYRLCCR HSV,HIV 23269800
DRAVPe01305 HD5[S23R] ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR HSV 23269800
DRAVPe01306 HD5[T7R] ATCYCRRGRCATRESLSGVCEISGRLYRLCCR HSV 23269800
DRAVPe01307 HD5[L16R] ATCYCRTGRCATRESRSGVCEISGRLYRLCCR HSV 23269800
DRAVPe01350 H2-(1-15) ECRSTSYAGAVVNDL HSV 3040743
DRAVPe01351 H2-(4-15) STSYAGAVVNDL HSV 3040743
DRAVPe01352 H2-(7-15) YAGAVVNDL HSV 3040743
DRAVPe01353 H2-(8-15) AGAVVNDL HSV 3040743
DRAVPe01354 H2-(9-15) GAVVNDL HSV 3040743
DRAVPe01355 H2-(10-15) AVVNDL HSV 3040743
DRAVPe01356 H2-(11-15) VVNDL HSV 3040743
DRAVPe01357 Ac-H2-(7-15) YAGAVVNDL HSV 3040743
DRAVPe01358 H2-(7-15) amide YAGAVVNDL HSV 3040743
DRAVPe01359 Ac-H2-(7-15) amide YAGAVVNDL HSV 3040743
DRAVPe01360 Ac-H2-(11-15) VVNDL HSV 3040743
DRAVPe01361 [Tyr9]H2-(9-15) YAVVNDL HSV 3040743
DRAVPe01362 Ac-[Tyr9]H2-(9-15) YAVVNDL HSV 3040743
DRAVPe01363 [Tyr8]H2-(8-15) YGAVVNDL HSV 3040743
DRAVPe01364 Ac-[Tyr8]H2-(8-15) YGAVVNDL HSV 3040743
DRAVPe01365 [Ala7]H2-(7-15) AAGAVVNDL HSV 3040743
DRAVPe01366 [D-Tyr7]H2-(7-15) yAGAVVNDL HSV 3040743
DRAVPe01367 Ac-[D-Tyr7]H2-(7-15) yAGAVVNDL HSV 3040743
DRAVPe01368 [Tyr7(OMe)]H2-(7-15) XAGAVVNDL HSV 3040743
DRAVPe01369 Ac[Tyr7(OMe)]H2-(7-15) XAGAVVNDL HSV 3040743
DRAVPe01370 [desamino-Tyr7]H2-(7-15) XAGAVVNDL HSV 3040743
First 1 2 3 4 5 6 7 Last